Literature DB >> 30266375

Radiographic predictors of bone exposure in patients with stage 0 medication-related osteonecrosis of the jaws.

Akrivoula Soundia1, Danny Hadaya2, Sanjay M Mallya1, Tara L Aghaloo3, Sotirios Tetradis4.   

Abstract

OBJECTIVE: The aim of this study was to explore the radiographic appearance of stage 0 medication-related osteonecrosis of the jaws (MRONJ) and examine 5 radiographic parameters (trabecular sclerosis, cortical erosion, periosteal reaction, sequestration, and crater-like defect) as predictors of progression to bone exposure. STUDY
DESIGN: Twenty-three patients with a history of antiresorptive therapy, no bone exposure, and nonspecific signs and symptoms were included. Intraoral photographs, panoramic and cone beam computed tomography (CBCT) images at initial visit, and follow-up intraoral photographs were reviewed. Three patients had dental disease (DD), 10 patients with stage 0 MRONJ did not progress to bone exposure (NBE), and 10 patients progressed to bone exposure (BE). Radiographic parameters were scored as absent (0), localized (1), or extensive (2), and their sum formed the composite radiographic index (CRI).
RESULTS: DD patients demonstrated minimal radiographic findings, and their CRI was significantly lower than that of NBE and BE patients. Additionally, BE patients demonstrated a higher radiographic index compared with NBE patients. Intriguingly, sequestration was observed in the initial CBCT of 9 (90%) of 10 BE patients, whereas 80% of NBE patients showed absence of sequestration at initial CBCT examination.
CONCLUSIONS: CBCT imaging can aid in the differentiation of stage 0 MRONJ from dental disease. Radiographic sequestration at initial presentation can serve as a predictor of future bone exposure in patients with stage 0 MRONJ.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30266375      PMCID: PMC6295235          DOI: 10.1016/j.oooo.2018.08.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  33 in total

1.  Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw.

Authors:  Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Eduardo C A Santos; Shane P Drew; Kuei-Ching Hung; Mark M Schubert
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-04-12

2.  Nonexposed bisphosphonate-related osteonecrosis of the jaws: another clinical variant?

Authors:  Luis Junquera; Lorena Gallego
Journal:  J Oral Maxillofac Surg       Date:  2008-07       Impact factor: 1.895

3.  Bevacizumab and osteonecrosis of the jaw: incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer.

Authors:  Valentina Guarneri; David Miles; Nicholas Robert; Véronique Diéras; John Glaspy; Ian Smith; Christoph Thomssen; Laura Biganzoli; Tanya Taran; PierFranco Conte
Journal:  Breast Cancer Res Treat       Date:  2010-04-02       Impact factor: 4.872

4.  Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws?

Authors:  Hani Mawardi; Nathaniel Treister; Paul Richardson; Kenneth Anderson; Nikhil Munshi; Robert A Faiella; Sook-Bin Woo
Journal:  J Oral Maxillofac Surg       Date:  2009-03       Impact factor: 1.895

5.  Bisphosphonate-related osteonecrosis of the jaw: model and diagnosis with cone beam computerized tomography.

Authors:  C Barragan-Adjemian; L Lausten; D B Ang; M Johnson; J Katz; L F Bonewald
Journal:  Cells Tissues Organs       Date:  2008-08-15       Impact factor: 2.481

Review 6.  Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday.

Authors:  Michael McClung; Steven T Harris; Paul D Miller; Douglas C Bauer; K Shawn Davison; Larry Dian; David A Hanley; David L Kendler; Chui Kin Yuen; E Michael Lewiecki
Journal:  Am J Med       Date:  2012-11-20       Impact factor: 4.965

Review 7.  Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.

Authors:  Aliya A Khan; Archie Morrison; David A Hanley; Dieter Felsenberg; Laurie K McCauley; Felice O'Ryan; Ian R Reid; Salvatore L Ruggiero; Akira Taguchi; Sotirios Tetradis; Nelson B Watts; Maria Luisa Brandi; Edmund Peters; Teresa Guise; Richard Eastell; Angela M Cheung; Suzanne N Morin; Basel Masri; Cyrus Cooper; Sarah L Morgan; Barbara Obermayer-Pietsch; Bente L Langdahl; Rana Al Dabagh; K Shawn Davison; David L Kendler; George K Sándor; Robert G Josse; Mohit Bhandari; Mohamed El Rabbany; Dominique D Pierroz; Riad Sulimani; Deborah P Saunders; Jacques P Brown; Juliet Compston
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

8.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

9.  Radiographic Findings in Patients with Medication-Related Osteonecrosis of the Jaw.

Authors:  Camila Lopes Cardoso; Carolina Arrabal Barros; Cláudia Curra; Luciana Maria Paes da Silva Ramos Fernandes; Solange de Oliveira Braga Franzolin; Joel Santiago Ferreira Júnior; Carlos César De Antoni; Marcos Martins Curi
Journal:  Int J Dent       Date:  2017-03-02

10.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; E V McCloskey; H Johansson; C Cooper; R Rizzoli; J-Y Reginster
Journal:  Osteoporos Int       Date:  2012-10-19       Impact factor: 4.507

View more
  9 in total

1.  Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.

Authors:  Akishige Hokugo; Keiichi Kanayama; Shuting Sun; Kenzo Morinaga; Yujie Sun; QingQing Wu; Hodaka Sasaki; Hiroko Okawa; Courtney Evans; Frank H Ebetino; Mark W Lundy; Keivan Sadrerafi; Charles E McKenna; Ichiro Nishimura
Journal:  Bone       Date:  2019-03-26       Impact factor: 4.398

2.  Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study.

Authors:  Takuma Watanabe; Takeshi Yoshida; Sachi Akizuki; Shigeki Yamanaka; Kazumasa Nakao; Shizuko Fukuhara; Keita Asai; Ryuji Uozumi; Kazuhisa Bessho
Journal:  J Bone Miner Metab       Date:  2022-05-09       Impact factor: 2.626

3.  Correlation of dynamic contrast-enhanced bone perfusion with morphologic ultra-short echo time MR imaging in medication-related osteonecrosis of the jaw.

Authors:  Paul Schumann; Sarah Morgenroth; Florian A Huber; Niels J Rupp; Filippo Del Grande; Roman Guggenberger
Journal:  Dentomaxillofac Radiol       Date:  2021-08-18       Impact factor: 2.419

4.  Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.

Authors:  Ioannis Gkouveris; Danny Hadaya; Naseim Elzakra; Akrivoula Soundia; Olga Bezouglaia; Sarah M Dry; Flavia Pirih; Tara Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2022-07-11       Impact factor: 6.390

Review 5.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

Review 6.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

7.  Zoledronic Acid Deteriorates Soft and Hard Tissue Healing of Murine Tooth Extraction Sockets in a Dose-Dependent Manner.

Authors:  Ryohei Kozutsumi; Shinichiro Kuroshima; Haruka Kaneko; Muneteru Sasaki; Akira Ishisaki; Takashi Sawase
Journal:  Calcif Tissue Int       Date:  2021-08-07       Impact factor: 4.333

8.  Use and Evaluation of a Computer-Assisted Examination Method for the Diagnosis and Analysis of Medication-Related Osteonecrosis of the Jaw.

Authors:  Max Wilkat; Daman Deep Singh; Isabelle Lutz; Henriette Möllmann; Nils-Claudius Gellrich; Majeed Rana
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2020-07-15

9.  A Comparison of the Clinical and Radiological Extent of Denosumab (Xgeva®) Related Osteonecrosis of the Jaw: A Retrospective Study.

Authors:  Zineb Assili; Gilles Dolivet; Julia Salleron; Claire Griffaton-Tallandier; Claire Egloff-Juras; Bérengère Phulpin
Journal:  J Clin Med       Date:  2021-05-28       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.